WASHINGTON, June 16 (UPI) -- The U.S. Food and Drug Administration says it is ordering manufacturers of "conventional" antipsychotic drugs to include boxed warnings on the products.
... published on bmj.com today. Previous research has shown that second generation (atypical) antipsychotic drugs can increase the chances of patients having a stroke. But the risk of stroke associated ...
New research into the effects of antipsychotic drugs commonly prescribed to Alzheimer's patients concludes that the medication nearly doubles risk of death over three years. The study, funded by the ...
Newer antipsychotic drugs are linked to nearly doubling the odds of sudden death from a heart problem and may be riskier than older medicines, researchers say.
... , 1,515 (11 percent) were hospitalized for hyperglycemia. Those who were currently taking antipsychotic drugs had a higher risk of hospitalization than those who had stopped the medications more than ...
... Medicine, one of the JAMA/Archives journals. “Newer antipsychotic drugs (olanzapine, quetiapine fumarate and risperidone) ... in nursing homes, 6,853 received no antipsychotics, 6,853 received atypical ...
... first is the G-protein-dependent signaling pathway, and the other is the beta arrestin pathway.
Most antipsychotic drugs in use today were developed to target the G-protein signaling that occurs at ...
All drugs used to treat psychosis are linked to an increased risk of stroke, and dementia sufferers are at double the risk, according to a study published on bmj.com today.
... -label use (=non-approved use).
Clinical trials of antipsychotic drugs traditionally focus on acute clinical ... patients (50.0%) with no previous antipsychotic exposure showing significant weight gain ...
A federal judge in Brooklyn decided to unseal confidential materials about Eli Lilly’s top-selling antipsychotic drug, citing questions about the way drugs are approved for new uses.
Nearly every child who receives an antipsychotic medicine is first prescribed one of the second-generation, or “atypical” drugs, such as olanzapine and risperidone. However, there has never been ...
... for which the drugs had been approved.
Most people who received these "atypical antipsychotic" drugs, which are very powerful and have potentially severe side effects, had less serious mental ...
Antipsychotic drugs, such as olanzapine (Zyprexa), risperidone (Risperdal) and quetiapine (Seroquel), are commonly used to treat psychotic disorders like schizophrenia, but also bipolar disorder and ...
Antipsychotic drugs, such as olanzapine (Zyprexa), risperidone (Risperdal) and quetiapine (Seroquel), are commonly used to treat psychotic disorders like schizophrenia, but also bipolar disorder and ...
The U.S. Food and Drug Administration should consider approving a drug for people with schizophrenia who don't respond to other treatments, an advisory panel said Tuesday.
